(CNP) CenterPoint Energy - Ratings and Ratios
Electricity, Gas, Transmission, Distribution
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 18.1% |
| Value at Risk 5%th | 30.0% |
| Relative Tail Risk | 0.86% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.41 |
| Alpha | 25.35 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.465 |
| Beta | 0.182 |
| Beta Downside | 0.130 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.14% |
| Mean DD | 5.25% |
| Median DD | 4.68% |
Description: CNP CenterPoint Energy October 14, 2025
CenterPoint Energy, Inc. (NYSE:CNP) is a U.S. public-utility holding company that operates two regulated segments: Electric and Natural Gas. The Electric segment delivers transmission and distribution services, manages generation assets, and participates in wholesale power markets within Indiana. The Natural Gas segment sells intrastate gas, transports and distributes it across Indiana, Louisiana, Minnesota, Mississippi, Ohio, and Texas, and offers ancillary services such as home appliance maintenance and protection plans in selected states.
As of 31 December 2024, CenterPoint served roughly 2.82 million metered customers, owned 352 substations with a transformer capacity of 80,659 MVA, and operated about 219 miles of intrastate pipelines in Louisiana and Texas. Recent SEC filings show a regulated rate base of approximately $31 billion and a dividend yield near 4.2 %, reflecting the sector’s emphasis on stable cash flow. Capital-expenditure guidance for 2025 targets $2.2 billion, largely directed at grid modernization, renewable-energy integration, and pipeline integrity-key drivers given the ongoing push for decarbonization and the volatility of natural-gas prices.
For a data-driven deep-dive into CenterPoint’s valuation metrics, growth assumptions, and peer comparisons, you might explore ValueRay’s analytical tools to complement your research.
CNP Stock Overview
| Market Cap in USD | 26,108m |
| Sub-Industry | Multi-Utilities |
| IPO / Inception | 1970-01-02 |
| Return 12m vs S&P 500 | 15.6% |
| Analyst Rating | 3.53 of 5 |
CNP Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 2.22% |
| Yield on Cost 5y | 4.18% |
| Yield CAGR 5y | 2.29% |
| Payout Consistency | 94.9% |
| Payout Ratio | 51.2% |
CNP Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 11.47% |
| CAGR/Max DD Calmar Ratio | 0.63 |
| CAGR/Mean DD Pain Ratio | 2.18 |
| Current Volume | 4335.2k |
| Average Volume | 4924.3k |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (995.0m TTM) > 0 and > 6% of Revenue (6% = 545.2m TTM) |
| FCFTA -0.06 (>2.0%) and ΔFCFTA -2.67pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -30.75% (prev 5.07%; Δ -35.82pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 2.60b > Net Income 995.0m (YES >=105%, WARN >=100%) |
| Net Debt (22.87b) to EBITDA (3.54b) ratio: 6.45 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.51 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (656.0m) change vs 12m ago 1.23% (target <= -2.0% for YES) |
| Gross Margin 44.78% (prev 44.49%; Δ 0.28pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 20.67% (prev 19.96%; Δ 0.70pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.31 (EBITDA TTM 3.54b / Interest Expense TTM 893.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.11
| (A) -0.06 = (Total Current Assets 2.95b - Total Current Liabilities 5.74b) / Total Assets 45.05b |
| (B) 0.04 = Retained Earnings (Balance) 1.93b / Total Assets 45.05b |
| (C) 0.05 = EBIT TTM 2.06b / Avg Total Assets 43.97b |
| (D) 0.06 = Book Value of Equity 1.92b / Total Liabilities 34.01b |
| Total Rating: 0.11 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 39.10
| 1. Piotroski 3.50pt |
| 2. FCF Yield -5.79% |
| 3. FCF Margin -30.81% |
| 4. Debt/Equity 2.08 |
| 5. Debt/Ebitda 6.45 |
| 6. ROIC - WACC (= 2.11)% |
| 7. RoE 9.11% |
| 8. Rev. Trend -25.07% |
| 9. EPS Trend 26.42% |
What is the price of CNP shares?
Over the past week, the price has changed by +0.58%, over one month by -1.02%, over three months by +4.00% and over the past year by +29.29%.
Is CNP a buy, sell or hold?
- Strong Buy: 5
- Buy: 1
- Hold: 12
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the CNP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 42.7 | 7.8% |
| Analysts Target Price | 42.7 | 7.8% |
| ValueRay Target Price | 45.6 | 15.3% |
CNP Fundamental Data Overview November 19, 2025
P/E Trailing = 25.3101
P/E Forward = 21.0526
P/S = 2.8646
P/B = 2.3772
P/EG = 2.4404
Beta = 0.562
Revenue TTM = 9.09b USD
EBIT TTM = 2.06b USD
EBITDA TTM = 3.54b USD
Long Term Debt = 19.40b USD (from longTermDebt, last quarter)
Short Term Debt = 3.54b USD (from shortTermDebt, last quarter)
Debt = 22.94b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 22.87b USD (from netDebt column, last quarter)
Enterprise Value = 48.40b USD (26.11b + Debt 22.94b - CCE 646.0m)
Interest Coverage Ratio = 2.31 (Ebit TTM 2.06b / Interest Expense TTM 893.0m)
FCF Yield = -5.79% (FCF TTM -2.80b / Enterprise Value 48.40b)
FCF Margin = -30.81% (FCF TTM -2.80b / Revenue TTM 9.09b)
Net Margin = 10.95% (Net Income TTM 995.0m / Revenue TTM 9.09b)
Gross Margin = 44.78% ((Revenue TTM 9.09b - Cost of Revenue TTM 5.02b) / Revenue TTM)
Gross Margin QoQ = 50.99% (prev 47.69%)
Tobins Q-Ratio = 1.07 (Enterprise Value 48.40b / Total Assets 45.05b)
Interest Expense / Debt = 1.04% (Interest Expense 238.0m / Debt 22.94b)
Taxrate = 2.70% (7.00m / 259.0m)
NOPAT = 2.01b (EBIT 2.06b * (1 - 2.70%))
Current Ratio = 0.51 (Total Current Assets 2.95b / Total Current Liabilities 5.74b)
Debt / Equity = 2.08 (Debt 22.94b / totalStockholderEquity, last quarter 11.04b)
Debt / EBITDA = 6.45 (Net Debt 22.87b / EBITDA 3.54b)
Debt / FCF = -8.17 (negative FCF - burning cash) (Net Debt 22.87b / FCF TTM -2.80b)
Total Stockholder Equity = 10.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.21% (Net Income 995.0m / Total Assets 45.05b)
RoE = 9.11% (Net Income TTM 995.0m / Total Stockholder Equity 10.92b)
RoCE = 6.80% (EBIT 2.06b / Capital Employed (Equity 10.92b + L.T.Debt 19.40b))
RoIC = 6.14% (NOPAT 2.01b / Invested Capital 32.69b)
WACC = 4.03% (E(26.11b)/V(49.05b) * Re(6.69%) + D(22.94b)/V(49.05b) * Rd(1.04%) * (1-Tc(0.03)))
Discount Rate = 6.69% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 1.94%
Fair Price DCF = unknown (Cash Flow -2.80b)
EPS Correlation: 26.42 | EPS CAGR: 23.47% | SUE: 2.00 | # QB: 1
Revenue Correlation: -25.07 | Revenue CAGR: -11.11% | SUE: -0.36 | # QB: 0
Additional Sources for CNP Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle